Published in Stroke on May 05, 2005
The Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART): an adaptive design phase I dose-escalation study of high-dose lovastatin in acute ischemic stroke. Int J Stroke (2008) 1.65
Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke. Neurology (2016) 1.41
Neurorestorative treatment of stroke: cell and pharmacological approaches. NeuroRx (2006) 1.37
Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol (2007) 1.35
High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART). Cerebrovasc Dis (2009) 1.10
Statin treatment and functional outcome after ischemic stroke: case-control and meta-analysis. Stroke (2011) 1.03
Statins alone are ineffective in cerebral malaria but potentiate artesunate. Antimicrob Agents Chemother (2008) 1.00
Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia? BMC Neurol (2010) 0.96
Statins and clinical outcome of acute ischemic stroke: a systematic review. Int Arch Med (2010) 0.92
Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model. Malar J (2012) 0.90
Effect of prior medical treatments on ischemic stroke severity and outcome. Funct Neurol (2011) 0.89
Statin pre-treatment is associated with lower platelet activity and favorable outcome in patients with acute non-cardio-embolic ischemic stroke. Crit Care (2011) 0.85
Impact of hyperlipidemia and statins on ischemic stroke outcomes after intra-arterial fibrinolysis and percutaneous mechanical embolectomy. Cerebrovasc Dis (2009) 0.85
Statins in Acute Ischemic Stroke: A Systematic Review. J Stroke (2015) 0.83
Effect of previous statin therapy on severity and outcome in ischemic stroke patients: a population-based study. J Neurol (2012) 0.83
Statins for the prevention of stroke: a meta-analysis of randomized controlled trials. PLoS One (2014) 0.82
Early High-dosage Atorvastatin Treatment Improved Serum Immune-inflammatory Markers and Functional Outcome in Acute Ischemic Strokes Classified as Large Artery Atherosclerotic Stroke: A Randomized Trial. Medicine (Baltimore) (2016) 0.81
The effect of statin therapy in stroke outcome: a double blind clinical trial. Int J Prev Med (2012) 0.78
Association between statin use and short-term outcome based on severity of ischemic stroke: a cohort study. PLoS One (2014) 0.78
Effect of pre-stroke statin use on stroke severity and early functional recovery: a retrospective cohort study. BMC Neurol (2015) 0.76
Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke. Int J Mol Sci (2016) 0.75
The effect of statins on National Institutes of Health Stroke Scale (NiHSS) in Ischemic stroke. J Med Life (2015) 0.75
Effect of 20 mg/day Atorvastatin: Recurrent Stroke Survey in Chinese Ischemic Stroke Patients with Prior Intracranial Hemorrhage. J Clin Neurol (2013) 0.75
Pre and Post-stroke Use of Statins Improves Stroke Outcome. Indian J Community Med (2014) 0.75
Atorvastatin in stroke: a review of SPARCL and subgroup analysis. Vasc Health Risk Manag (2010) 0.75
HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke (2005) 0.75
Relationship between pre-stroke cardiovascular medication use and stroke severity. Eur J Clin Pharmacol (2015) 0.75
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
Stroke. Lancet (2008) 9.51
Good laboratory practice: preventing introduction of bias at the bench. Stroke (2008) 3.27
Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials. Stroke (2008) 2.58
Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann Neurol (2007) 2.46
Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke (2013) 2.36
Pixel-by-pixel spatiotemporal progression of focal ischemia derived using quantitative perfusion and diffusion imaging. J Cereb Blood Flow Metab (2003) 2.34
Notes from the field: Heartland virus disease - United States, 2012-2013. MMWR Morb Mortal Wkly Rep (2014) 2.33
Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke (2007) 2.25
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet (2011) 2.16
Characterizing the diffusion/perfusion mismatch in experimental focal cerebral ischemia. Ann Neurol (2004) 2.14
Functional, perfusion and diffusion MRI of acute focal ischemic brain injury. J Cereb Blood Flow Metab (2005) 2.01
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials. Stroke (2007) 1.62
Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. Stroke (2009) 1.61
Normobaric hyperoxia delays perfusion/diffusion mismatch evolution, reduces infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab (2007) 1.57
Differential recovery of behavioral status and brain function assessed with functional magnetic resonance imaging after mild traumatic brain injury in the rat. Crit Care Med (2007) 1.56
Dynamic tracking of acute ischemic tissue fates using improved unsupervised ISODATA analysis of high-resolution quantitative perfusion and diffusion data. J Cereb Blood Flow Metab (2004) 1.52
Acute postischemic renormalization of the apparent diffusion coefficient of water is not associated with reversal of astrocytic swelling and neuronal shrinkage in rats. AJNR Am J Neuroradiol (2002) 1.51
Effects of reperfusion on ADC and CBF pixel-by-pixel dynamics in stroke: characterizing tissue fates using quantitative diffusion and perfusion imaging. J Cereb Blood Flow Metab (2004) 1.49
Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Stroke (2009) 1.48
Reprint: Good laboratory practice: preventing introduction of bias at the bench. J Cereb Blood Flow Metab (2008) 1.47
Acute stroke imaging research roadmap. AJNR Am J Neuroradiol (2008) 1.41
Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices. Cerebrovasc Dis (2008) 1.37
The Virtual International Stroke Trials Archive. Stroke (2007) 1.34
A concerted appeal for international cooperation in preclinical stroke research. Stroke (2013) 1.32
Statistical prediction of tissue fate in acute ischemic brain injury. J Cereb Blood Flow Metab (2005) 1.30
Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol (2008) 1.30
Separating changes in the intra- and extracellular water apparent diffusion coefficient following focal cerebral ischemia in the rat brain. Magn Reson Med (2002) 1.26
International, multicenter randomized preclinical trials in translational stroke research: it's time to act. J Cereb Blood Flow Metab (2012) 1.24
Normobaric hyperoxia and delayed tPA treatment in a rat embolic stroke model. J Cereb Blood Flow Metab (2008) 1.24
Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in Acute Ischemic Stroke trial. Stroke (2011) 1.22
The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats. J Neurosci Methods (2003) 1.19
AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke (2010) 1.19
Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Substudy. Cerebrovasc Dis (2005) 1.16
Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging. Stroke (2005) 1.11
Laser Doppler flowmetry predicts occlusion but not tPA-mediated reperfusion success after rat embolic stroke. Exp Neurol (2008) 1.09
Stroke: working toward a prioritized world agenda. Stroke (2010) 1.05
Microsphere-induced embolic stroke: an MRI study. Magn Reson Med (2004) 1.03
Development, expansion, and use of a stroke clinical trials resource for novel exploratory analyses. Int J Stroke (2012) 1.02
Characterizing tissue fate after transient cerebral ischemia of varying duration using quantitative diffusion and perfusion imaging. Stroke (2007) 1.02
Animal models of focal brain ischemia. Exp Transl Stroke Med (2009) 1.01
Stroke: working toward a prioritized world agenda. Cerebrovasc Dis (2010) 1.01
Normobaric hyperoxia - a promising approach to expand the time window for acute stroke treatment. Cerebrovasc Dis (2005) 1.00
The proteasome inhibitor VELCADE reduces infarction in rat models of focal cerebral ischemia. Neurosci Lett (2006) 1.00
Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good? Stroke (2010) 0.99
IFN-gamma is an absolute requirement for spontaneous acceptance of liver allografts. Am J Transplant (2003) 0.99
Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor. Stroke (2011) 0.98
Stimulating circle of Willis nerve fibers preserves the diffusion-perfusion mismatch in experimental stroke. Stroke (2007) 0.97
Long-term changes of functional MRI-based brain function, behavioral status, and histopathology after transient focal cerebral ischemia in rats. Stroke (2006) 0.96
Perfusion and diffusion imaging in acute focal cerebral ischemia: temporal vs. spatial resolution. Brain Res (2005) 0.95
Cardiac workup of ischemic stroke: can we improve our diagnostic yield? Stroke (2009) 0.94
Improving the accuracy of perfusion imaging in acute ischemic stroke. Ann Neurol (2011) 0.94
Comparison of ischemic lesion evolution in embolic versus mechanical middle cerebral artery occlusion in Sprague Dawley rats using diffusion and perfusion imaging. Stroke (2006) 0.93
Recent increases in efficiency in cigarette nicotine delivery: implications for tobacco control. Nicotine Tob Res (2014) 0.93
Reprint: Good laboratory practice: preventing introduction of bias at the bench. Int J Stroke (2009) 0.93
Effects of intravenous dimethyl sulfoxide on ischemia evolution in a rat permanent occlusion model. J Cereb Blood Flow Metab (2005) 0.92
Long-term statin therapy and CSF cholesterol levels: implications for Alzheimer's disease. Dement Geriatr Cogn Disord (2009) 0.91
Comparison between coated vs. uncoated suture middle cerebral artery occlusion in the rat as assessed by perfusion/diffusion weighted imaging. Neurosci Lett (2006) 0.91
Visualization of clot lysis in a rat embolic stroke model: application to comparative lytic efficacy. Stroke (2011) 0.91
Differential recovery of multimodal MRI and behavior after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab (2006) 0.91
The effects of reformulation: improved therapeutic index. Curr Urol Rep (2008) 0.88
Spectacular shrinking deficit: insights from multimodal magnetic resonance imaging after embolic middle cerebral artery occlusion in Sprague-Dawley rats. J Cereb Blood Flow Metab (2007) 0.88
MRI of stroke using hyperpolarized 129Xe. NMR Biomed (2010) 0.88
Current practice versus willingness to enroll in clinical trials: paradox among vascular neurologists about treatment for acute ischemic stroke. Stroke (2010) 0.88
Cortical Vein Thrombosis as a Mimic for Isolated Cortical Subarachnoid Hemorrhage and Transient Ischemic Attack. Case Rep Neurol (2010) 0.87
Characterization of gadolinium-based dynamic susceptibility contrast perfusion measurements in permanent and transient MCAO models with volumetric based validation by CASL. J Cereb Blood Flow Metab (2009) 0.86
Middle cerebral artery occlusion during MR-imaging: investigation of the hyperacute phase of stroke using a new in-bore occlusion model in rats. Brain Res Brain Res Protoc (2004) 0.85
Visualization of cortical spreading depression using manganese-enhanced magnetic resonance imaging. Magn Reson Med (2005) 0.85
Ischemic lesion volume determination on diffusion weighted images vs. apparent diffusion coefficient maps. Brain Res (2009) 0.84
Rosai-Dorfman disease of the pleura: a rare extranodal presentation. Hum Pathol (2003) 0.84
Stroke: working toward a prioritized world agenda. Int J Stroke (2010) 0.84
Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder. Drugs Aging (2012) 0.83
Acute ischemic stroke therapy. Expert Rev Cardiovasc Ther (2010) 0.81
Posterior versus anterior circulation infarction: how different are the neurological deficits? Stroke (2012) 0.81
Use of telemedicine to increase thrombolysis and advance care in acute ischemic stroke. Cerebrovasc Dis (2009) 0.81
Multi-modal approach for investigating brain and behavior changes in an animal model of traumatic brain injury. J Neurotrauma (2013) 0.80
Investigation of techniques to quantify in vivo lesion volume based on comparison of water apparent diffusion coefficient (ADC) maps with histology in focal cerebral ischemia of rats. Magn Reson Imaging (2004) 0.80
REPRINT: International, multicenter randomized preclinical trials in translational stroke research: it is time to act. Stroke (2012) 0.80
Human autologous in vitro models of glioma immunogene therapy using B7-2, GM-CSF, and IL12. Can J Neurol Sci (2002) 0.79
Paroxysmal atrial fibrillation in cryptogenic stroke. Ther Clin Risk Manag (2011) 0.79
Prophylactic neuroprotection. Curr Drug Targets (2007) 0.79
Applications of diffusion/perfusion magnetic resonance imaging in experimental and clinical aspects of stroke. Curr Atheroscler Rep (2004) 0.78
Pharmacokinetics of once-daily trospium chloride 60 mg extended release and twice-daily trospium chloride 20 mg in healthy adults. J Clin Pharmacol (2009) 0.78
Considering the role of heparin and low-molecular-weight heparins in acute ischemic stroke. Stroke (2002) 0.78
Role of heparin and low-molecular-weight heparins in the management of acute ischemic stroke. Expert Rev Cardiovasc Ther (2006) 0.78
Partial-volume effect on ischemic tissue-fate delineation using quantitative perfusion and diffusion imaging on a rat stroke model. Magn Reson Med (2004) 0.78
Study of the population pharmacokinetic characteristics of once-daily trospium chloride 60 mg extended-release capsules in patients with overactive bladder and in healthy subjects. Clin Drug Investig (2013) 0.77
Why the United States needs a network for stroke clinical trials. Stroke (2013) 0.77
Proactive personality and the successful job search: a field investigation with college graduates. J Appl Psychol (2006) 0.77
Disparities in access to healthy and unhealthy foods in central Massachusetts: implications for public health policy. J Am Coll Nutr (2015) 0.77
Devices, drugs, and the Food and Drug Administration: increasing implications for ischemic stroke. Stroke (2005) 0.76
The perils of combination antithrombotic therapy and potential resolutions. Circulation (2011) 0.76